Roche’s New Pharma Head Vows To Expand Development Of Targeted Therapies
This article was originally published in The Pink Sheet Daily
Executive Summary
Daniel O’Day, new pharma head at Roche, aims to increase the proportion of medicines developed together with diagnostic tests, underscoring the rising importance and success of personal health care.